CA19‐9 Does Not Predict cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis Undergoing Liver Transplantion

Adrian Fisher, Neil D. Theise, Albert Min, Eytan Mor, Sukru Emre, Adam Pearl, Myron E. Schwartz, Charles M. Miller, Patricia A. Sheiner – 1 March 1995 – The results of liver transplantation in patients with cholangiocarcinoma have been poor. It has been suggested that elevated serum CA19‐9 levels predict cholangiocarcinoma in patients with primary sclerosing cholangitis. We analyzed the predictive value of CA19‐9 antigen as a marker of cholangiocarcinoma in patients with primary sclerosing cholangitis evaluated for liver transplantation.

Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection

Robert M. Hoffmann, Helmut M. Diepolder, Reinhart Zachoval, Franz‐Maximilian Zwiebel, Maria‐Christina Jung, Siegfried Scholz, Hans Nitschko, Gert Riethmüller, Gerd R. Pape – 1 March 1995 – In acute and chronic viral disease the specific response of CD4+ T lymphocytes to certain viral proteins is an essential part of antiviral effector mechanisms. In hepatitis C virus infection, the contribution of the immune system and particularly of CD4+ T lymphocytes to the pathogenesis of disease is unknown.

Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter study

Antoni Rimola, Joan M. Salmerón, Gerardo Clemente, Luis Rodrigo, Antoni Obrador, M. Luisa Miranda, Carlos Guarner, Ramon Planas, Ricard Solá, Victor Vargas, Fernando Casafont, Francesc Marco, Miquel Navasa, Rafael Bañares, Vicente Arroyo, Joan Rodés – 1 March 1995 – Cefotaxime (CTX) is considered one of the first‐choice antibiotics in the therapy of spontaneous bacterial peritonitis (SBP) in cirrhosis. Because CTX is largely metabolized in the liver, this drug may also be effective in SBP by administering lower doses than those habitually used.

Human immunodeficiency virus infection as risk factor for mother‐to‐child hepatitis C virus transmission; Persistence of anti–hepatitis C virus in children is associated with the mother's anti–hepatitis C virus immunoblotting pattern

Paola Manzini, Giorgio Saracco, Antonella Cerchier, Caterina Riva, Alberto Musso, Emanuela Ricotti, Elvia Palomba, Carlo Scolfaro, Giorgio Verme, Ferruccio Bonino, Pier Angelo Tovo – 1 February 1995 – To determine the rate of vertical transmission of hepatitis C virus (HCV), we prospectively studied 45 babies born to anti‐HCV–positive women with or without con‐comitant infection with the human immunodeficiency virus (HIV).

Bilirubin conjugate changes in the bile of gallbladders containing gallstones

Carl A. Goresky, Ellen R. Gordon, E. John Hinchey, Gerald M. Fried – 1 February 1995 – Gallbladder bile was obtained at laparoscopic cholcystecotomy from 31 patients with gallstones, and duodenal aspirates from 18 normal controls. Bile pigments (9 conjugates and unconjugated bilirubin) were analyzed by high‐performance liquid chromatography. The average proportional composition of the bile pigments from the patients with gallstones was characteristically different from the controls.

Effect of functional grade and etiology on in vivo hepatic phosphorus‐31 magnetic resonance spectroscopy in cirrhosis: Biochemical basis of spectral appearances

David K. Menon, Janet Sargentoni, Simon D. Taylor‐Robinson, Jimmy D. Bell, I. Jane Cox, David J. Bryant, Glyn A. Coults, Keith Rolles, Andrew K. Burroughs, Marsha Y. Margan – 1 February 1995 – Hepatic phosphorus‐31 magnetic resonance spectroscopy (31P MRS) was undertaken in 85 patients with histoloically proven cirrhosis of varying etiologies and functional severity. Reference data were acquired from 16 healthy volunteers who had no history or evidence of liver disease or alcohol abuse.

Subscribe to